LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Microchip Separates White Blood Cells from Whole Blood

By LabMedica International staff writers
Posted on 14 Aug 2013
Image: The microfluidic chip works by mimicking the physiological process of 'cell rolling' where patterns of adhesive molecules are used to draw out neutrophils (blue) from a stream of blood (red) into a parallel buffer stream as shown in the bottom panel (Photo courtesy of Suman Bose and Rohit Karnik).
Image: The microfluidic chip works by mimicking the physiological process of 'cell rolling' where patterns of adhesive molecules are used to draw out neutrophils (blue) from a stream of blood (red) into a parallel buffer stream as shown in the bottom panel (Photo courtesy of Suman Bose and Rohit Karnik).
A new microchip can quickly separate white blood cells from samples of whole blood, eliminating any preliminary processing steps, which could make it difficult to integrate into point-of-care medical devices.

The scientists aim is to integrate the microchip into a portable diagnostic device that may be used to directly analyze patient blood samples for signs of inflammatory disease such as sepsis—particularly in regions of developing countries where diagnostic lab equipment is not readily available.

The scientists pumped tiny volumes of blood through the microchip and recovered a highly pure stream of white blood cells, virtually devoid of other blood components such as platelets and red blood cells. The team found that the sorted cells were undamaged and functional, potentially enabling clinicians not only to obtain a white blood cell count, but also to use the cells to perform further genetic or clinical tests.

The chip works by mimicking the physiological process of “cell rolling” where patterns of adhesive molecules are used to draw out neutrophils from a stream of blood into a parallel buffer stream. For blood samples, Prof. Karnik, Rohit Karnik, an associate professor of mechanical engineering at Massachusetts Institute of Technology (MIT; Cambridge, MA, USA) and Suman Bose worked in parallel on a new microchip design. The team etched a pattern of microscopically thin gold stripes, diagonal to the flow of fluid through the chip. They then attached molecules of P-selectin along each gold stripe. Before flowing blood through the chip, the team tested the design with a culture of two types of leukemia cells. Through video imaging, they observed that one cell type was drawn out of the stream, attaching and rolling briefly along a sticky gold stripe before jumping to a neighboring line. Eventually, after a series of jumps and rolls, the cells rolled the rest of the way along a stripe, then into a separate gutter, or channel, where they flowed into a collector.

Rohit Karnik, an associate professor of mechanical engineering at MIT, said that the key to recovering such pure, functional cells lies in the microchip’s adaption of the body’s natural process of cell rolling.

“We believe that because we’re using a very biomimetic process, the cells are happier,” said Prof. Karnik an associate professor of mechanical engineering at MIT, “It’s a more gentle process, and the cells are functionally viable.” Prof. Karnik and colleagues published their results in the July 2013 issue of the journal Scientific Reports.

Related Links:
Massachusetts Institute of Technology


Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Homocysteine Quality Control
Liquichek Homocysteine Control
Automated MALDI-TOF MS System
EXS 3000

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more